Analystreport

BioLineRx Ltd. (NASDAQ: BLRX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.

BioLineRx Ltd. - American Depositary Shares  (BLRX) 
Last biolinerx ltd. - american depositary shares earnings: 5/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.biolinerx.com